search
Back to results

Evaluation of Glass Ionomer Cement Modified With Chlorhexidine and Titanium Dioxide in Primary Molars (RCT)

Primary Purpose

Dental Caries in Children

Status
Recruiting
Phase
Phase 2
Locations
Egypt
Study Type
Interventional
Intervention
glass ionomer-chlorhexidine
glass ionomer-titanium dioxide powder
glass ionomer
Sponsored by
Ain Shams University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dental Caries in Children

Eligibility Criteria

4 Years - 8 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria: The teeth will be primary molars selected from patients presented to the outpatient clinic that are Healthy patients. Children having at least one primary molar with only occlusal caries having dentine lesions (ADA caries classification system mostly 1 or 2 please check) Dentine caries must be apparent visually or radiographically Exclusion Criteria: .Teeth with pulp involvement, those suffering from pain, irreversible pulpits or pulp necrosis. Patients with history of active para-functional oral habits, xerostomia. Patients who will have difficulties in cooperating

Sites / Locations

  • faculty of dentistry .Ain shams universityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Active Comparator

Arm Label

glass ionomer-chlorhexidine

glass ionomer -titanium dioxide powder.

glass ionomer

Arm Description

Outcomes

Primary Outcome Measures

clinical performance
the clinical performance of different restorations will be evaluated by USPHS evaluation criteria

Secondary Outcome Measures

antibacterial effect
bacterial count reduction will be assessed in dentin

Full Information

First Posted
December 1, 2022
Last Updated
December 1, 2022
Sponsor
Ain Shams University
search

1. Study Identification

Unique Protocol Identification Number
NCT05645029
Brief Title
Evaluation of Glass Ionomer Cement Modified With Chlorhexidine and Titanium Dioxide in Primary Molars (RCT)
Official Title
Antimicrobial Activity and Clinical Performance of Glass Ionomer Cement Modified With Chlorhexidine and Titanium Dioxide in Primary Molars: A Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
December 2022
Overall Recruitment Status
Recruiting
Study Start Date
September 1, 2022 (Actual)
Primary Completion Date
September 1, 2023 (Anticipated)
Study Completion Date
November 15, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ain Shams University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
to investigate the effect of modifying GIC with different formulations on the antibacterial activity and clinical performance in reference to unmodified glass ionomer restorative materials.
Detailed Description
The study will be a randomized clinical trial, with a 1:1:1 allocation ratio and parallel arms that will enroll children from the outpatient clinic of pediatric dentistry department, Ain shams University Blinding: Enrolled children, assessors and statistician will be blinded. Randomization: block randomization with blocks of 6. A maximum of 2 primary molars per patient will receive the same treatment. Allocation concealment: Allocation will be done just before placement of a restoration to avoid performance bias during the cavity preparation. The envelope will be only checked after cavity preparation when the filling material will be chosen Groups Teeth will be randomly allocated to 3 groups all groups will receive the same cavity preparation and then a different restoration. Group A: glass ionomer powder will be mixed with chlorhexidine Group B: glass ionomer will be mixed with titanium dioxide powder. Group C: will be the positive control, glass ionomer with no additives Sample Size The sample size: A total number is 39 (13 in each group) is calculated using Epicalc program version 1.02 assuming a power of 80 % and alpha=0.05. The sample size is based on percentage of success of ART restorations at 9 months follow up (GIC with chlorhexidine and GIC with miswak) was 60% and 90%, respectively.13 Intervention: Teeth will be randomly allocated to the three groups. Care givers and patients involved will be informed about the study procedures, an informed consent form and assent will be obtained. Group A: Conventional glass ionomer cement (Fuji IX, GC, Tokyo, Japan) will be used and modified by incorporating CHX diacetate (0.5% wt) into the powder of the glass ionomer (Fuji IX, GC, Tokyo, Japan) Group B: Conventional glass ionomer cement (Fuji IX, GC, Tokyo, Japan) will be used and modified by incorporating titanium dioxide (3% wt) in glass-based powder component of the GIC. Group C: Conventional glass ionomer Cavity preparation and baseline sampling Rubber dam will be placed for isolation of the designated teeth. A step wise caries removal technique will be employed28. Access to the cavity was created using a high-speed dental handpiece fitted with a Meisinger (Hager & Meisinger - Germany) round diamond bur (801G-16) , and all the caries on the lateral walls, caries in the dentine-enamel junction and undermined enamel was removed. Using a discoid Lascod (Lascod S.p.A Italy) excavator (#1) elective removal of superficial soft necrotic dentine was attempted, leaving behind demineralized wet, leathery dentine centrally on the pulpal wall (Leathery dentine is characterized by being removed in flakes by the excavator) 8,27 A different sterile excavator of the size will be used with very light pressure to take a sample of dentine from the center of the cavity floor center, the sample will be inserted in a brain heart infusion tube and sent to the microbiology lab within 1 hour then added to the culture to measure the bacterial load for the baseline sample by measuring the colony forming units (CFU) 29,30. Blood agar will be used to quantify the total bacterial count, while mitis-salivaris -bacitracin agar will be used to selectively quantify S.mutans. After cavity preparation, an endodontic file will be used to record the depth of the cavity to aid with the re-entry, and then the operator will reveal the patient's group by opening an envelope. GC cavity conditioner" (GC Japan) will be applied to the cavity walls for 20 seconds leaving the floor unconditioned then the material will be packed into the cavity using a ball burnisher and pressed into it with a petroleum jelly covered gloves for 30 s (press finger technique). Then the excess material will be removed using a carver, and occlusion will be checked and adjusted, then Equia coat varnish (GC Japan) will be applied. Follow-up The patients will be recalled at 6 and 9 months for clinical performance evaluation by the USPHS evaluation criteria (table 1). Visual and clinical inspection with 3.5x magnification will be done with the help of a sharp explorer by a blinded secondary investigator.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dental Caries in Children

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
39 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
glass ionomer-chlorhexidine
Arm Type
Experimental
Arm Title
glass ionomer -titanium dioxide powder.
Arm Type
Experimental
Arm Title
glass ionomer
Arm Type
Active Comparator
Intervention Type
Other
Intervention Name(s)
glass ionomer-chlorhexidine
Intervention Description
chlorhexidine will be added to glass ionomer
Intervention Type
Other
Intervention Name(s)
glass ionomer-titanium dioxide powder
Intervention Description
titanium dioxide will be added to glass ionomer
Intervention Type
Other
Intervention Name(s)
glass ionomer
Intervention Description
glass ionomer will be used without any additives
Primary Outcome Measure Information:
Title
clinical performance
Description
the clinical performance of different restorations will be evaluated by USPHS evaluation criteria
Time Frame
9 months
Secondary Outcome Measure Information:
Title
antibacterial effect
Description
bacterial count reduction will be assessed in dentin
Time Frame
9 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
8 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: The teeth will be primary molars selected from patients presented to the outpatient clinic that are Healthy patients. Children having at least one primary molar with only occlusal caries having dentine lesions (ADA caries classification system mostly 1 or 2 please check) Dentine caries must be apparent visually or radiographically Exclusion Criteria: .Teeth with pulp involvement, those suffering from pain, irreversible pulpits or pulp necrosis. Patients with history of active para-functional oral habits, xerostomia. Patients who will have difficulties in cooperating
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
mohamed diaa zein Alabdin, professor
Phone
(202)22639088
Email
diaa67@dent.asu.edu.eg
Facility Information:
Facility Name
faculty of dentistry .Ain shams university
City
Cairo
ZIP/Postal Code
11566
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mohmed diaa, professor
Phone
01006030255
Email
diaa67@dent.asu.edu.eg

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Evaluation of Glass Ionomer Cement Modified With Chlorhexidine and Titanium Dioxide in Primary Molars (RCT)

We'll reach out to this number within 24 hrs